Literature DB >> 23257609

Platelet-function testing in patients undergoing neurovascular procedures: caught between a rock and a hard place.

J Comin1, D F Kallmes.   

Abstract

In the context of neurointerventional procedures, clopidogrel hyper-responsiveness has been associated with hemorrhage; on the other hand, clopidogrel resistance has been associated with thromboembolism. This might seem to make a compelling argument in favor of routine platelet testing. Our reading of the literature leads us to conclude that routine platelet testing in neurointerventional procedures is not, unfortunately, ready for prime time.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23257609      PMCID： PMC7964478          DOI： 10.3174/ajnr.A3440

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  47 in total

Review 1.  Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis.

Authors:  Dániel Aradi; András Komócsi; Matthew J Price; Thomas Cuisset; Hasan Ari; Dobri Hazarbasanov; Dietmar Trenk; Dirk Sibbing; Marco Valgimigli; Laurent Bonello
Journal:  Int J Cardiol       Date:  2012-06-15       Impact factor: 4.164

2.  Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials.

Authors:  Dominick J Angiolillo; David J Schneider; Deepak L Bhatt; William J French; Matthew J Price; Jorge F Saucedo; Tamaz Shaburishvili; Kurt Huber; Jayne Prats; Tiepu Liu; Robert A Harrington; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

3.  Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.

Authors:  Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Manel Sabaté; Pilar Jimenez-Quevedo; Rosana Hernández; Raul Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Carlos Macaya
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

4.  The EFFect of hIgh-dose ClopIdogrel treatmENT in patients with clopidogrel resistance (the EFFICIENT trial).

Authors:  Hasan Ari; Hakan Ozkan; Ali Karacinar; Selma Ari; Vedat Koca; Tahsin Bozat
Journal:  Int J Cardiol       Date:  2011-01-15       Impact factor: 4.164

5.  Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.

Authors:  C Goh; L Churilov; P Mitchell; R Dowling; B Yan
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-28       Impact factor: 3.825

6.  Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.

Authors:  Piergiovanni Buonamici; Rossella Marcucci; Angela Migliorini; Gian Franco Gensini; Alberto Santini; Rita Paniccia; Guia Moschi; Anna Maria Gori; Rosanna Abbate; David Antoniucci
Journal:  J Am Coll Cardiol       Date:  2007-06-04       Impact factor: 24.094

7.  Platelet function in acute myocardial infarction treated with direct angioplasty.

Authors:  M Gawaz; F J Neumann; I Ott; A Schiessler; A Schömig
Journal:  Circulation       Date:  1996-01-15       Impact factor: 29.690

8.  Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.

Authors:  Rossella Marcucci; Anna Maria Gori; Rita Paniccia; Betti Giusti; Serafina Valente; Cristina Giglioli; Piergiovanni Buonamici; David Antoniucci; Rosanna Abbate; Gian Franco Gensini
Journal:  Circulation       Date:  2008-12-31       Impact factor: 29.690

9.  Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.

Authors:  Shlomi Matetzky; Paul Fefer; Boris Shenkman; David Varon; Naphtali Savion; Hanoch Hod
Journal:  Am J Cardiol       Date:  2008-06-12       Impact factor: 2.778

10.  Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.

Authors:  Thomas Cuisset; Corinne Frere; Jacques Quilici; Pierre-Emmanuel Morange; Jean-Philippe Mouret; Laurent Bali; Pierre-Julien Moro; Marc Lambert; Marie-Christine Alessi; Jean Louis Bonnet
Journal:  JACC Cardiovasc Interv       Date:  2008-12       Impact factor: 11.195
View more
  12 in total

Review 1.  Critical Care of Brain Reperfusion.

Authors:  Shailesh Male; Chris Nickele; Lucas Elijovich
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

2.  Flow Diversion for Intracranial Aneurysm Management: A New Standard of Care.

Authors:  Fawaz Al-Mufti; Krishna Amuluru; Chirag D Gandhi; Charles J Prestigiacomo
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

3.  Retrospective Analysis of Delayed Intraparenchymal Hemorrhage after Flow-Diverter Treatment: Presentation of a Retrospective Multicenter Trial.

Authors:  A Benaissa; C Tomas; F Clarençon; N Sourour; D Herbreteau; L Spelle; S Gallas; A-C Januel; A L Gaultier; L Pierot
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-29       Impact factor: 3.825

4.  Antiplatelet Management for Stent-Assisted Coiling and Flow Diversion of Ruptured Intracranial Aneurysms: A DELPHI Consensus Statement.

Authors:  J M Ospel; P Brouwer; F Dorn; A Arthur; M E Jensen; R Nogueira; R Chapot; F Albuquerque; C Majoie; M Jayaraman; A Taylor; J Liu; J Fiehler; N Sakai; K Orlov; D Kallmes; J F Fraser; L Thibault; M Goyal
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-17       Impact factor: 3.825

5.  Safety of Prasugrel loading in ruptured blister like aneurysm treated with a Pipeline device.

Authors:  Rajsrinivas Parthasarathy; Vipul Gupta; Aditya Gupta
Journal:  Br J Radiol       Date:  2018-03-22       Impact factor: 3.039

6.  Outcome Study of the Pipeline Embolization Device with Shield Technology in Unruptured Aneurysms (PEDSU).

Authors:  D Atasoy; N Kandasamy; J Hart; J Lynch; S-H Yang; D Walsh; C Tolias; T C Booth
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-14       Impact factor: 3.825

7.  Platelet Testing is Associated with Worse Clinical Outcomes for Patients Treated with the Pipeline Embolization Device.

Authors:  W Brinjikji; G Lanzino; H J Cloft; A H Siddiqui; R A Hanel; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

Review 8.  Management of unruptured incidentally found intracranial saccular aneurysms.

Authors:  Vikram A Mehta; Charis A Spears; Jihad Abdelgadir; Timothy Y Wang; Eric W Sankey; Andrew Griffin; C Rory Goodwin; Ali Zomorodi
Journal:  Neurosurg Rev       Date:  2020-10-06       Impact factor: 3.042

9.  Delayed ipsilateral parenchymal hemorrhage following treatment of intracranial aneurysms with flow diverter.

Authors:  Catherine Tomas; Azzedine Benaissa; Denis Herbreteau; Krzysztof Kadziolka; Laurent Pierot
Journal:  Neuroradiology       Date:  2013-11-17       Impact factor: 2.804

10.  Dual Testing to Achieve Low On-treatment Platelet Reactivity for Aneurysm Embolization.

Authors:  Halitcan Batur; Mehmet A Topcuoglu; Sinan Balci; Ethem M Arsava; Anil Arat
Journal:  Clin Neuroradiol       Date:  2021-04-12       Impact factor: 3.649
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.